A Study of Sacituzumab Govitecan in People With Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Mesothelioma
Related studies linked through entity extraction aliases.
A Study of SGN-MesoC2 in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of VET3-TGI in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
- Status
- TERMINATED
- Phase
- PHASE1
Folinic Acid for Prevention of Pemetrexed-induced Toxicity
- Status
- UNKNOWN
- Phase
- PHASE4
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
- Status
- SUSPENDED
- Phase
- PHASE2
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Studying the Clinical Trial Experiences of Patients With Mesothelioma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI
- Status
- RECRUITING
- Phase
- PHASE2
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
- Status
- COMPLETED
- Phase
- N/A